Search research articles
Contact Us
Filters
Showing results (171-180 of 267) with videos related to
Page
of 27
Sort By:
Oncotarget
|
April 16, 2016
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs
Grégory Fouquet, Véronique Debuysscher, Hakim Ouled-Haddou, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)
Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
World Journal of Urology
|
January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)
Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
Oncotarget
|
January 23, 2016
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
Hicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, et al.
Nature Physics
|
January 23, 2023
Mechanical stress driven by rigidity sensing governs epithelial stability
Surabhi Sonam, Lakshmi Balasubramaniam, Shao-Zhen Lin, et al.
The French Journal of Urology
|
October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025
Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pharmaceutics
|
December 23, 2022
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 11, 2025
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30)
Paul Sargos, Géraldine Pignot, Carine Bellera, et al.
Frontiers in Toxicology
|
May 2, 2024
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop
Scott A Fisher, Kimberley Patrick, Tracy Hoang, et al.
Cancer Management and Research
|
January 11, 2020
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 267) with videos related to
Sort By:
Page
of 27
Oncotarget
|
April 16, 2016
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs
Grégory Fouquet, Véronique Debuysscher, Hakim Ouled-Haddou, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)
Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
World Journal of Urology
|
January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)
Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
Oncotarget
|
January 23, 2016
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
Hicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, et al.
Nature Physics
|
January 23, 2023
Mechanical stress driven by rigidity sensing governs epithelial stability
Surabhi Sonam, Lakshmi Balasubramaniam, Shao-Zhen Lin, et al.
The French Journal of Urology
|
October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025
Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pharmaceutics
|
December 23, 2022
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 11, 2025
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30)
Paul Sargos, Géraldine Pignot, Carine Bellera, et al.
Frontiers in Toxicology
|
May 2, 2024
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop
Scott A Fisher, Kimberley Patrick, Tracy Hoang, et al.
Cancer Management and Research
|
January 11, 2020
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, et al.
Page
of 27